Cannabis Use Disorder Clinical Trial Pipeline Gains Momentum

The federal executive order on cannabis rescheduling does NOT make recreational marijuana legalโ€”it eases research restrictions and tax burdens, but full legalization still requires an act of Congress. OpenPR reports that the clinical trial pipeline for cannabis use disorder (CUD) treatments is gaining momentum, with pharmaceutical R&D intensifying focus on targeted therapies. Aelis Farma is advancing AEF0117, a selective CB1 modulator, through Phase II trials.

Read More

Cannabis Rescheduling Update: Advocates Eye AG Bondi Hearing for Status Report

Cannabis rescheduling could ease research restrictions and reduce tax burdens on the industry, but it won’t make recreational marijuana legalโ€”only Congress can do that. Reform advocates are watching Attorney General Pam Bondi’s scheduled appearance before the House Judiciary Committee for an update on where cannabis rescheduling stands. Pennsylvania House Democrats are calling on the GOP Senate to follow their lead on legalization, as Gov.

Read More